BUD
Anheuser-Busch Inbev SA
$81.72
▲ 1.1%Updated Today 3:42 PM ET
BUD at a glance — five pillars scored 0–100 from real filed financials.
Overall: Neutral · 50/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
▲ Up 15.1% over the last 12 months
Market Cap
$155.21B
P/E
22.25x
Forward P/E (est.)
21.1x
ROE
4.3%
Revenue Growth
3.6%
EPS Growth
5.5%
Profit Margin
11.9%
FCF Yield
7.4%
Debt / Equity
0.84x
ROIC
8.0%
Interest Coverage
4.48x
Current Ratio
0.72x
Dividend Yield
1.1%
Implied Growth (rev. DCF)
1.6%
Rating Score
50/100
Anheuser-Busch Inbev SA (BUD) is a large-cap company in the Beverages industry, part of the Consumer Staples sector of the S&P 500, with a market value around $155.21B.
In its latest reported year it generated about $59.32B in revenue and $6.84B in net profit.
Our model rates BUD Neutral (50/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
Evidence of durable competitive advantage in the filed financials (10 years of history).
Some durable-advantage evidence, but not across the board — dig into which ingredient is weak and whether it's cyclical or structural.
55.0% average over the last 3 years
±3.1 pts around 58.1% across 10 years
grew in 5 of the last 9 year-over-year periods
positive in 10 of 10 years
8.0% latest fiscal year
A moat can't be proven by numbers alone — this scores the evidence a durable advantage leaves behind (pricing power, consistency, returns on capital), computed the same way for every stock. Pair it with the business overview before concluding anything.
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what BUD's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. BUD trades near $81.72, above its 50-day average ($80.15) and 200-day average ($70.42). Price above both averages, with the shorter one above the longer, is the textbook definition of an uptrend — momentum favours buyers.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 39 it is in neutral territory — neither stretched nor washed out.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently negative — short-term momentum is fading.
Volatility — ATR. Average True Range is the typical daily move. BUD's is $1.81 (~2.2% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. Over the last month BUD found buyers near $77.58 (support) and sellers near $85.56 (resistance); its 52-week range is $56.97–$85.56. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 0.8× the 20-day average — about normal. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.
4Y CAGR
2.2%
Revenue moved from $45.52B in 2016 to $59.32B in 2025, a 3.0% compound annual growth rate. The most recent year was roughly flat (3.6%) year over year. Slower, mature growth is common for established businesses.
Gross Margin
55.9%
Operating Margin
26.0%
Net Margin
11.5%
ROE
4.3%
Anheuser-Busch Inbev SA keeps about 11.9% of each sales dollar as net profit, with a 55.9% gross margin and 26.0% operating margin. Return on equity is 4.3% and return on invested capital about 8.0%. Margins are moderate — typical of a competitive but profitable business.
Total Debt
$73.01B
Net Debt
$61.38B
Net Debt / EBITDA
3.98x
Debt / Equity
0.84x
Leverage: debt-to-equity is 0.8x, and operating profit covers interest about 4.5x, with a current ratio of 0.7x. That is a moderate, manageable debt load for most businesses. It carries roughly $73.01B of total debt against $11.64B of cash.
Operating CF
$14.88B
Free Cash Flow
$11.23B
FCF Margin
18.9%
In the latest year Anheuser-Busch Inbev SA produced about $14.88B of operating cash flow and $11.23B of free cash flow after capital spending. That is a free-cash-flow yield of about 7.4% on today's price. Strong cash generation funds dividends, buybacks, and reinvestment.
Can the payout survive a bad year? Scored from filed cash flow, earnings coverage, and the raise/cut record.
The dividend is being paid, but coverage or consistency is thinner than an income investor should rely on without a closer look.
Dividend yield
1.1%
Total paid (latest FY)
$4.54B
History on record
10 years
dividend uses 40% of free cash flow
66% of net income paid out
total dividends increased 1 year in a row
payout was cut at least once in the last 10 years
Coverage uses the latest fiscal year as filed with the SEC; the streak counts total dollars paid (per-share figures can carry split artifacts). Educational information, not income advice.
P/E
22.25x
P/S
2.72x
P/B
1.43x
EV / EBITDA
10.29x
BUD trades at 22.2x trailing earnings (about 21.1x on estimated forward earnings), 2.7x sales, and 1.4x book value. Reverse-engineering today's price implies the market expects roughly 1.6% long-term free-cash-flow growth. That is a fairly typical valuation for a profitable company.
A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.
DCF fair value / share
$104.79
Current price
$81.72
Starting FCF (latest 10-K)
$11.23B
Growth, years 1–5
3.6%
Fade to terminal, years 6–10
2.5%
Discount rate
9.0%
Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.
Where BUD sits versus its Consumer Staples sector peers in the S&P 500.
Bands show the middle half (25th–75th percentile) of the 48 Consumer Staples companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.
How BUD stacks up against its Consumer Staples peers — valuation, profitability, and growth versus the sector median.
In the Consumer Staples sector (74 S&P 500 companies), BUD ranks #21 of 74 by our overall rating. It trades at roughly in line versus the sector on earnings (22.2x P/E vs. 22.2x median) with a lower return on equity (4.3% vs. 18.1%) and faster revenue growth (3.6% vs. 3.4%).
P/E vs sector
22.2x
median 22.2x
ROE vs sector
4.3%
median 18.1%
Growth vs sector
3.6%
median 3.4%
Sector rank
#21
of 74 by rating
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Consumer Staples companies by sub-industry and size. Sector median is across all 74 S&P 500 names in the sector. Educational, not a recommendation.
Project revenue → earnings → price. Edit the assumptions to build your own case.
2030 price target (Base Case)
$0.00 – $0.00
vs. $81.72 today · expected CAGR -6% – 4%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $61.69B | $64.16B | $66.73B | $69.40B | $72.17B |
| Net income | $7.40B | $7.70B | $8.01B | $8.33B | $8.66B |
| EPS | $3.90 | $4.05 | $4.22 | $4.38 | $4.56 |
| Share price (low) | $50.67 | $52.70 | $54.81 | $57.00 | $59.28 |
| Share price (high) | $85.75 | $89.19 | $92.75 | $96.46 | $100.32 |
| CAGR (low–high) | -38% / 5% | -20% / 4% | -12% / 4% | -9% / 4% | -6% / 4% |
Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.
The case for BUD:
- Healthy free-cash-flow yield (~7.4%) funds buybacks and dividends.
- As an established S&P 500 member in Consumer Staples, it brings scale and a long operating history.
The case against BUD:
- Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the picture is mixed: Anheuser-Busch Inbev SA is a large-cap consumer staples business growing at a mature pace, with modest profitability, and a heavier debt load to watch. It trades at 22.2x earnings, which our model scores Neutral (50/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
Analyst Ratings
What 32 Wall Street analysts covering BUD recommend (July 2026). Consensus is a useful sanity check — not a substitute for your own homework.
Analysts have turned more positive over the last three months (+6 pts of buy ratings).
Latest SEC Filings
BUD's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen.
In the Idea Lab
BUD — frequently asked questions
Is BUD a good stock to buy?
We don't give buy or sell advice. Our model rates Anheuser-Busch Inbev SA Neutral (50/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.
What is BUD's rating on The Stocks School?
Anheuser-Busch Inbev SA currently scores 50/100 (Neutral) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.
How our ratings work →Where does BUD's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from Anheuser-Busch Inbev SA's SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for BUD calculated?
It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.
Is this BUD analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell BUD. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.